Antithrombotic Therapy at the End of Life: The PEACE Study

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07338071

Acronym

PEACE

Enrollment

410

Registered

2026-01-13

Start date

2026-01-31

Completion date

2027-11-30

Last updated

2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Care

Keywords

antithrombotic therapy, end of life, palliative care

Brief summary

Antithrombotic Therapy at the End of Life: The PEACE Study is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

Interventions

DRUGantithrombotic drugs

use of antithrombotic drug

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults (≥18 years) hospitalized and referred to Palliative Care (home-based or residential) at the discretion of the attending physician. * Signed informed consent

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of antithrombotic drug use	at enrollment	Calculation of the prevalence of antithrombotic drug use in hospitalized patients referred to Palliative Care pathway.

Countries

Italy

Contacts

Primary ContactRoberto Pola

roberto.pola@policlinicogemelli.it+390630157075

Backup ContactRosa Talerico

rosa.talerico@unicatt.it+390630157075

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026